The lupus nephritis therapies market is expected to increase from current market size of US$ 1.8 billion in 2022 to US$ 5.67 billion by 2033, with a compound annual growth rate (CAGR) of 11% from 2023 to 2033. The disease’s increasing prevalence, more public awareness, and the emergence of innovative, cutting-edge treatments are all contributing …